OhioHealth Leverages AI to Revolutionize Diabetic Retinopathy Screening
MedCity News
|
Contributed by: Kate Gamble
Summary
OhioHealth is integrating AI technology into its primary care practices to improve diabetic retinopathy screening, crucial for diabetes management. Partnering with Digital Diagnostics, the health system utilizes the LumineticsCore platform to autonomously diagnose diabetic retinopathy from retinal images taken during routine visits, providing same-day results. Since the partnership's initiation, OhioHealth's diabetic patient population has grown significantly, with a goal of increasing screening rates—previously at 35% in 2021. The AI platform includes tools for pre-visit planning to identify patients in need of eye exams and integrates diagnostic results into the electronic health record system for immediate access.
